Vaneck UCITS ETFs PLC - Vaneck Genomics And Healthcare Innovators UCITS ETF (LON:CURE)
London · Delayed Price · Currency is GBP · Price in USD 20.22
+0.22 (1.09%)
Last updated: May 11, 2026, 4:28 PM GMT
LON:CURE Holdings Information
LON:CURE is an equity ETF with a total of 51 individual holdings. The top holdings are Regeneron Pharmaceuticals stock at 8.11%, Vertex Pharmaceuticals at 7.68%, Veeva Systems at 6.84%, DexCom at 6.53%, and Alnylam Pharmaceuticals at 6.07%.
Total Holdings
51
Top 10 Percentage
62.12%
Asset Class
Equity
ETF Category
Theme
Assets
9.47M
PE Ratio
26.10
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | REGN | Regeneron Pharmaceuticals, Inc. | 8.11% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.68% |
| 3 | VEEV | Veeva Systems Inc. | 6.84% |
| 4 | DXCM | DexCom, Inc. | 6.53% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 6.07% |
| 6 | NTRA | Natera, Inc. | 5.97% |
| 7 | ILMN | Illumina, Inc. | 5.77% |
| 8 | MRNA | Moderna, Inc. | 5.34% |
| 9 | BNTX | BioNTech SE | 5.06% |
| 10 | GH | Guardant Health, Inc. | 4.76% |
| 11 | PODD | Insulet Corporation | 3.18% |
| 12 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.08% |
| 13 | IONS | Ionis Pharmaceuticals, Inc. | 2.88% |
| 14 | HKG: 6618 | JD Health International Inc. | 2.70% |
| 15 | ASX: PME | Pro Medicus Limited | 2.39% |
| 16 | QGEN | Qiagen N.V. | 2.10% |
| 17 | HIMS | Hims & Hers Health, Inc. | 1.79% |
| 18 | CRSP | CRISPR Therapeutics AG | 1.69% |
| 19 | PTCT | PTC Therapeutics, Inc. | 1.62% |
| 20 | STO: SECT.B | Sectra AB (publ) | 1.53% |
| 21 | TYO: 2413 | M3, Inc. | 1.28% |
| 22 | IRTC | iRhythm Holdings, Inc. | 1.19% |
| 23 | DOCS | Doximity, Inc. | 1.19% |
| 24 | HKG: 1548 | Genscript Biotech Corporation | 1.06% |
| 25 | GRAL | GRAIL, Inc. | 0.90% |
As of May 8, 2026